These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 26756274)
1. Addressing issues associated with evaluating prediction models for survival endpoints based on the concordance statistic. Wang M; Long Q Biometrics; 2016 Sep; 72(3):897-906. PubMed ID: 26756274 [TBL] [Abstract][Full Text] [Related]
2. Assessing predictive accuracy of survival regressions subject to nonindependent censoring. Wang M; Long Q; Chen C; Zhang L Stat Med; 2020 Feb; 39(4):469-480. PubMed ID: 31814158 [TBL] [Abstract][Full Text] [Related]
3. The inverse-probability-of-censoring weighting (IPCW) adjusted win ratio statistic: an unbiased estimator in the presence of independent censoring. Dong G; Mao L; Huang B; Gamalo-Siebers M; Wang J; Yu G; Hoaglin DC J Biopharm Stat; 2020 Sep; 30(5):882-899. PubMed ID: 32552451 [TBL] [Abstract][Full Text] [Related]
4. Concordance indices with left-truncated and right-censored data. Hartman N; Kim S; He K; Kalbfleisch JD Biometrics; 2023 Sep; 79(3):1624-1634. PubMed ID: 35775234 [TBL] [Abstract][Full Text] [Related]
5. Two-stage estimation to adjust for treatment switching in randomised trials: a simulation study investigating the use of inverse probability weighting instead of re-censoring. Latimer NR; Abrams KR; Siebert U BMC Med Res Methodol; 2019 Mar; 19(1):69. PubMed ID: 30935369 [TBL] [Abstract][Full Text] [Related]
6. Concordance for prognostic models with competing risks. Wolbers M; Blanche P; Koller MT; Witteman JC; Gerds TA Biostatistics; 2014 Jul; 15(3):526-39. PubMed ID: 24493091 [TBL] [Abstract][Full Text] [Related]
7. Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy. O'Brien MF; Cronin AM; Fearn PA; Smith B; Stasi J; Guillonneau B; Scardino PT; Eastham JA; Vickers AJ; Lilja H J Clin Oncol; 2009 Aug; 27(22):3591-7. PubMed ID: 19506163 [TBL] [Abstract][Full Text] [Related]
8. Machine learning for survival analysis: a case study on recurrence of prostate cancer. Zupan B; Demsar J; Kattan MW; Beck JR; Bratko I Artif Intell Med; 2000 Aug; 20(1):59-75. PubMed ID: 11185421 [TBL] [Abstract][Full Text] [Related]
9. Model selection for survival individualized treatment rules using the jackknife estimator. Honvoh GD; Cho H; Kosorok MR BMC Med Res Methodol; 2022 Dec; 22(1):328. PubMed ID: 36550398 [TBL] [Abstract][Full Text] [Related]
10. Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy. Brockman JA; Alanee S; Vickers AJ; Scardino PT; Wood DP; Kibel AS; Lin DW; Bianco FJ; Rabah DM; Klein EA; Ciezki JP; Gao T; Kattan MW; Stephenson AJ Eur Urol; 2015 Jun; 67(6):1160-1167. PubMed ID: 25301759 [TBL] [Abstract][Full Text] [Related]
11. Correcting for dependent censoring in routine outcome monitoring data by applying the inverse probability censoring weighted estimator. Willems S; Schat A; van Noorden MS; Fiocco M Stat Methods Med Res; 2018 Feb; 27(2):323-335. PubMed ID: 26988930 [TBL] [Abstract][Full Text] [Related]
12. On logistic regression with right censored data, with or without competing risks, and its use for estimating treatment effects. Blanche PF; Holt A; Scheike T Lifetime Data Anal; 2023 Apr; 29(2):441-482. PubMed ID: 35799026 [TBL] [Abstract][Full Text] [Related]
13. Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer. Walz J; Chun FK; Klein EA; Reuther A; Saad F; Graefen M; Huland H; Karakiewicz PI J Urol; 2009 Feb; 181(2):601-7; discussion 607-8. PubMed ID: 19084864 [TBL] [Abstract][Full Text] [Related]
14. Identifying the Most Informative Prediction Tool for Cancer-specific Mortality After Radical Prostatectomy: Comparative Analysis of Three Commonly Used Preoperative Prediction Models. Boehm K; Larcher A; Beyer B; Tian Z; Tilki D; Steuber T; Karakiewicz PI; Heinzer H; Graefen M; Budäus L Eur Urol; 2016 Jun; 69(6):1038-43. PubMed ID: 26272236 [TBL] [Abstract][Full Text] [Related]
15. Calibration plots for multistate risk predictions models. Pate A; Sperrin M; Riley RD; Peek N; Van Staa T; Sergeant JC; Mamas MA; Lip GYH; O'Flaherty M; Barrowman M; Buchan I; Martin GP Stat Med; 2024 Jun; 43(14):2830-2852. PubMed ID: 38720592 [TBL] [Abstract][Full Text] [Related]
16. Estimating the concordance probability in a survival analysis with a discrete number of risk groups. Heller G; Mo Q Lifetime Data Anal; 2016 Apr; 22(2):263-79. PubMed ID: 26022558 [TBL] [Abstract][Full Text] [Related]
17. Efficacy, Predictive Factors, and Prediction Nomograms for Rauscher I; Düwel C; Haller B; Rischpler C; Heck MM; Gschwend JE; Schwaiger M; Maurer T; Eiber M Eur Urol; 2018 May; 73(5):656-661. PubMed ID: 29358059 [TBL] [Abstract][Full Text] [Related]
18. Generalized pairwise comparisons for censored data: An overview. Deltuvaite-Thomas V; Verbeeck J; Burzykowski T; Buyse M; Tournigand C; Molenberghs G; Thas O Biom J; 2023 Feb; 65(2):e2100354. PubMed ID: 36127290 [TBL] [Abstract][Full Text] [Related]
19. Prioritized concordance index for hierarchical survival outcomes. Cheung LC; Pan Q; Hyun N; Katki HA Stat Med; 2019 Jul; 38(15):2868-2882. PubMed ID: 30957257 [TBL] [Abstract][Full Text] [Related]
20. Inverse probability weighted estimators of vaccine effects accommodating partial interference and censoring. Chakladar S; Rosin S; Hudgens MG; Halloran ME; Clemens JD; Ali M; Emch ME Biometrics; 2022 Jun; 78(2):777-788. PubMed ID: 33768557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]